Actinium Pharmaceuticals Growth Metrics (2010-2025) | ATNM

Growth Metrics Dec2010 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) 0.03M-1.55M-1.90M
EBITDA Margin Growth (3y) (Quarter) 1.55M
EBITDA Margin (QoQ) (Quarter) 0.05M-0.10M-0.09M-3.22M3.44M-1.69M-0.43M
EBIT Margin Growth (1y) (Quarter) 0.03M-1.55M-1.90M
EBIT Margin Growth (3y) (Quarter) 1.55M
EBIT Margin (QoQ) (Quarter) 0.05M-0.10M-0.09M-3.22M3.44M-1.69M-0.43M
EBT Margin Growth (1y) (Quarter) 0.03M-1.55M-1.90M
EBT Margin Growth (3y) (Quarter) 1.61M
EBT Margin (QoQ) (Quarter) 0.05M-0.10M-0.09M-3.22M3.44M-1.69M-0.43M
Enterprise Value Growth (1y) (Quarter) -0.15%-42.41%-35.98%-39.74%-31.09%21.80%26.05%29.85%11.45%5.74%5.20%22.28%30.35%32.12%
Enterprise Value Growth (3y) (Quarter) -5.15%-1.63%1.58%3.37%19.93%21.93%23.99%
Enterprise Value (QoQ) (Quarter) 42.97%-13.36%-0.68%5.21%7.43%-61.19%3.87%2.59%13.16%3.84%9.09%7.59%-9.62%-2.36%8.57%8.26%10.91%10.10%
FCF Margin Growth (1y) (Quarter) 0.03M6.32M-1.04M
FCF Margin (QoQ) (Quarter) -0.08M-0.07M-1.95M2.13M6.21M-7.43M
Interest Coverage Ratio Growth (1y) (Quarter) 107.62%224.04%-1,991.04%
Interest Coverage Ratio (QoQ) (Quarter) 111.95%407.91%-258.85%18.55%-187.76%
Net Margin Growth (1y) (Quarter) 0.03M-1.56M-1.90M
Net Margin Growth (3y) (Quarter) 1.61M
Net Margin (QoQ) (Quarter) 0.05M-0.10M-0.09M-3.21M3.43M-1.69M-0.43M
Operating Margin Growth (1y) (Quarter) 0.03M-1.55M-1.90M
Operating Margin Growth (3y) (Quarter) 1.55M
Operating Margin (QoQ) (Quarter) 0.05M-0.10M-0.09M-3.22M3.44M-1.69M-0.43M
Return on Assets Growth (1y) (Quarter) -10.00-3.001.00-6.00-20.00-29.00-28.00-17.000.00M7.00-8.00-22.00-19.00
Return on Assets Growth (3y) (Quarter) -30.00-24.00-31.00-41.00-40.00-27.00
Return on Assets (QoQ) (Quarter) -11.00-43.00-1.70M-5.00-7.00-2.004.002.00-4.00-8.00-10.00-7.00-3.003.007.000.00M-6.003.0010.00
Return on Capital Employed Growth (1y) (Quarter) -12.00-4.001.00-6.00-23.00-34.00-35.00-25.00-6.004.00-10.00-27.00-23.00
Return on Capital Employed Growth (3y) (Quarter) -41.00-33.00-41.00-56.00-53.00-36.00
Return on Capital Employed (QoQ) (Quarter) -34.000.01M-6.00-9.00-1.005.002.00-5.00-8.00-12.00-9.00-6.003.006.001.00-10.005.0012.00
Return on Equity Growth (1y) (Quarter) 0.01M-5.00-19.00-17.00-17.00-31.00-49.00-65.00-74.00-50.00-10.006.00-33.00-107.00-141.00
Return on Equity Growth (3y) (Quarter) -86.00-78.00-75.00-114.00-167.00-200.00-230.00
Return on Equity (QoQ) (Quarter) 2.00-295.000.00M0.00M11.00-5.00-8.00-2.00-3.00-4.00-8.00-16.00-21.00-19.00-17.008.0019.00-3.00-56.00-36.00-39.00
Return on Invested Capital (QoQ) (Quarter) -38.00
Return on Sales Growth (1y) (Quarter) 314.00-0.02M-0.02M0.03M-0.04M-0.09M
Return on Sales Growth (3y) (Quarter) 0.02M-0.03M
Return on Sales (QoQ) (Quarter) 491.00-0.00M-869.00-0.03M0.03M-0.02M-0.00M0.02M-0.04M-0.06M-0.03M